Use access key #2 to skip to page content.
$8.08 -0.37 (-4.38%)
7/8/2008 4:00 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating:
****

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

View All Commentary (AOB)

Recs

6

Avatar tuffsledding (99.89) Submitted: 5/13/08 10:47 PM : Outperform Start Price: $12.12 AOB Score: -23.55

Expect volatility, but if Chinese pharmaceutical usage begins to rise from its current very low level (compared to western countries), this company will reap huge benefits. With the growth of Chinese economy, rapid increase in disposable income and the desire to adopt western ways, this could be a rocket (or a dud, if the naysayers are correct). Not for the faint of heart, but a worthwhile gamble here in CAPS.

Report this Post Replies: 0 | Reply

Featured Broker Partners